Search Results - "Luqmani, R."

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by Yates, M, Watts, R A, Bajema, I M, Cid, M C, Crestani, B, Hauser, T, Hellmich, B, Holle, J U, Laudien, M, Little, M A, Luqmani, R A, Mahr, A, Merkel, P A, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Yalçındağ, N, Jayne, D R, Mukhtyar, C

“…In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody…”
Get more information

Hydroxychloroquine retinopathy by Yusuf, I H, Sharma, S, Luqmani, R, Downes, S M

“…Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and…”
Get full text

Modification and validation of the Birmingham Vasculitis Activity Score (version 3) by Mukhtyar, C, Lee, R, Brown, D, Carruthers, D, Dasgupta, B, Dubey, S, Flossmann, O, Hall, C, Hollywood, J, Jayne, D, Jones, R, Lanyon, P, Muir, A, Scott, D, Young, L, Luqmani, R A

“…Comprehensive multisystem clinical assessment using the Birmingham Vasculitis Activity score (BVAS) is widely used in therapeutic studies of systemic…”
Get more information

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides by Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., Hoffman, G. S., Jayne, D. R., Kallenberg, C. G. M., Lamprecht, P., Langford, C. A., Luqmani, R. A., Mahr, A. D., Matteson, E. L., Merkel, P. A., Ozen, S., Pusey, C. D., Rasmussen, N., Rees, A. J., Scott, D. G. I., Specks, U., Stone, J. H., Takahashi, K., Watts, R. A.

Get full text

EULAR recommendations for the management of large vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis. An expert group (10 rheumatologists, 3…”
Get more information

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force by Mukhtyar, C, Flossmann, O, Hellmich, B, Bacon, P, Cid, M, Cohen-Tervaert, J W, Gross, W L, Guillevin, L, Jayne, D, Mahr, A, Merkel, P A, Raspe, H, Scott, D, Witter, J, Yazici, H, Luqmani, R A

“…We undertook a systematic literature review as a background to the European League Against Rheumatism (EULAR) recommendations for conducting clinical trials in…”
Get more information

EULAR recommendations for the management of primary small and medium vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. An expert group (consisting of…”
Get more information

European Headache Federation recommendations for neurologists managing giant cell arteritis by Mollan, S. P., Paemeleire, K., Versijpt, J., Luqmani, R., Sinclair, A. J.

“…Background and aim Giant cell arteritis (GCA) remains a medical emergency because of the risk of sudden irreversible sight loss and rarely stroke along with…”
Get full text

Clinical features and structured clinical evaluation of vasculitis by Ponte, C., Águeda, A.F., Luqmani, R.A.

“…Systemic vasculitides are a group of heterogeneous conditions with overlapping patterns of clinical and laboratory manifestations. Moreover, clinical features…”
Get full text

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future by Hellmich, B., Águeda, A. F., Monti, S., Luqmani, R.

“…Purpose of Review Guidelines for the management of large vessel vasculitides have been recently updated by several scientific societies. We have evaluated the…”
Get full text

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials by Robson, Joanna, Doll, Helen, Suppiah, Ravi, Flossmann, Oliver, Harper, Lorraine, Höglund, Peter, Jayne, David, Mahr, Alfred, Westman, Kerstin, Luqmani, Raashid

“…Granulomatosis with polyangiitis and microscopic polyangiitis are ANCA-associated vasculitides (AAVs). The Vasculitis Damage Index (VDI) quantifies damage…”
Get full text

Nomenclature and classification of vasculitis – update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS) by Luqmani, R. A., Suppiah, R., Grayson, P. C., Merkel, P. A., Watts, R.

“…Summary Classification of vasculitis remains unsatisfactory. This is largely because the pathogenetic mechanisms of this family of related disorders have not…”
Get full text

Mortality in systemic vasculitis: a systematic review by Phillip, R, Luqmani, R

“…There has been a considerable improvement in the survival of patients with systemic vasculitis since the introduction of immunosuppressive therapy and improved…”
Get full text

Response to ‘Comment on: ‘A new era for giant cell arteritis’’ by Mollan, S. P., Quick, V., Sinclair, A. J., Luqmani, R.

Get full text

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases by Javaid, M K, Forestier-Zhang, L, Watts, L, Turner, A, Ponte, C, Teare, H, Gray, D, Gray, N, Popert, R, Hogg, J, Barrett, J, Pinedo-Villanueva, R, Cooper, C, Eastell, R, Bishop, N, Luqmani, R, Wordsworth, P, Kaye, J

“…Research into rare diseases is becoming more common, with recognition of the significant diagnostic and therapeutic care gaps. Registries are considered a key…”
Get full text

British society for rheumatology and british health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years) by LUQMANI, R, HENNELL, S, MOHAMMED, R, OLIVER, S, STABLEFORD, Z, WALSH, D, WASHBROOK, C, WEBB, F, ESTRACH, C, BIRRELL, F, BOSWORTH, A, DAVENPORT, G, FOKKE, C, GOODSON, N, JEFFRESON, P, LAMB, E

Get full text

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis by Flossmann, O, Baslund, B, Bruchfeld, A, Tervaert, J W Cohen, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R A, Nemoto, K, Tesar, V, Jayne, D R W

“…Conventional therapy of Wegener's granulomatosis with cyclophosphamide and corticosteroids is limited by incomplete remissions and a high relapse rate. The…”
Get more information

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies by Ding, Tina, Ledingham, Jo, Luqmani, Raashid, Westlake, Sarah, Hyrich, Kimme, Lunt, Mark, Kiely, Patrick, Bukhari, Marwan, Abernethy, Rikki, Bosworth, Ailsa, Ostor, Andrew, Gadsby, Kate, McKenna, Frank, Finney, Diana, Dixey, Josh, Deighton, Chris

Get full text

Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response by Pandit, H., Vlychou, M., Whitwell, D., Crook, D., Luqmani, R., Ostlere, S., Murray, D. W., Athanasou, N. A.

“…Clinical, radiological and histological findings were analysed in four patients who developed bilateral pseudotumours following metal-on-metal (MoM)…”
Get full text

Development of comprehensive disease assessment in systemic vasculitis by Flossmann, O, Bacon, P, de Groot, K, Jayne, D, Rasmussen, N, Seo, P, Westman, K, Luqmani, R

“…The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological…”
Get full text